Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Felzartamab in Graves' Disease
NCT07722546Phase 2Recruiting
- Sponsor
- Biogen
- Start
- Jul 2026
- Primary completion
- Jan 2028
- Countries
- 2
01
Overview
A Phase 2 trial of felzartamab in Graves' disease, sponsored by Biogen. Started Jul 2026; status: recruiting.
02
Drugs
felzartamab
03
Conditions
Graves' disease
Beyond the preview
Go deeper on NCT07722546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07722546.